NDC 62795-1005 Bhi Constipation
Dioscorea Villosa Tuber, Sodium Chloride, And Strychnos Nux-vomica Seed Tablet Oral
NDC Product Code 62795-1005
Proprietary Name: Bhi Constipation What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name: Dioscorea Villosa Tuber, Sodium Chloride, And Strychnos Nux-vomica Seed What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Drug Use Information
Drug Use InformationThe drug use information is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate. This information is not individual medical advice and does not substitute for the advice of a health care professional. Always ask a health care professional for complete information about this product and your specific health needs.
- This product is used as constipation relief tabletsrelieves:• constipation• bowel irregularity• bloating
NDC Code Structure
- 62795 - Medinatura Inc
- 62795-1005 - Bhi Constipation
NDC 62795-1005-3
Package Description: 1 BOTTLE in 1 CARTON > 100 TABLET in 1 BOTTLE
NDC Product Information
Bhi Constipation with NDC 62795-1005 is a human over the counter drug product labeled by Medinatura Inc. The generic name of Bhi Constipation is dioscorea villosa tuber, sodium chloride, and strychnos nux-vomica seed. The product's dosage form is tablet and is administered via oral form.
Dosage Form: Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Bhi Constipation Active Ingredient(s)
What is the Active Ingredient(s) List?This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
- DIOSCOREA VILLOSA TUBER 4 [hp_X]/1
- SODIUM CHLORIDE 200 [hp_X]/1
- STRYCHNOS NUX-VOMICA SEED 8 [hp_X]/1
Inactive Ingredient(s)
About the Inactive Ingredient(s)The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.
- LACTOSE (UNII: J2B2A4N98G)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
Administration Route(s)
What are the Administration Route(s)?The translation of the route code submitted by the firm, indicating route of administration.
- Oral - Administration to or by way of the mouth.
Pharmacologic Class(es)
What is a Pharmacological Class?These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Product Labeler Information
What is the Labeler Name?Name of Company corresponding to the labeler code segment of the Product NDC.
Labeler Name: Medinatura Inc
Labeler Code: 62795
Marketing Category: UNAPPROVED HOMEOPATHIC - What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Start Marketing Date: 08-30-2014 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Listing Expiration Date: 12-31-2023 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
Exclude Flag: N - NO What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".
* Please review the disclaimer below.
Bhi Constipation Product Label Images
Bhi Constipation Product Labeling Information
The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
Product Labeling Index
- Active Ingredients
- Inactive Ingredients
- Purpose
- Uses
- Directions
- Warnings
- Keep Out Of Reach Of Children
Active Ingredients
Each tablet contains: *Dioscorea villosa 4X, Natrum muriaticum 200X, *Nux vomica 8X 100 mg each.*Natural Ingredients
Inactive Ingredients
Lactose, Magnesium stearate
Purpose
Constipation Relief TabletsRelieves:• Constipation• Bowel Irregularity• Bloating
Uses
For the temporary relief of minor constipation, bowel irregularity, bloating
Directions
At first sign of symptoms: Adults and children 4 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours.Standard dosage: Adults and children 4 years and older: 3 tablets per day, taking 1 tablet every 4 to 6 hours. For children under 4, consult your health professional.Allow tablets to dissolve completely in the mouth, do not swallow.
Warnings
If pregnant or breast-feeding, ask a health professional before use.Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted.Do not use if known sensitivity to BHI Constipation or any of its ingredients exists.
Keep Out Of Reach Of Children
Keep out of reach of children.
* Please review the disclaimer below.